Skip to main content
Earnings Labs
Veru Inc. logo

Veru Inc. (VERU)

NASDAQ·Healthcare·Biotechnology

$2.27

+2.71%

Mkt Cap $39.48M

Analyst Ratings

Buy

2

Hold

0

Sell

0

Price Target (4 analysts)

$4.00

Range $3.00 – $5.00

Implied Upside

+76.2%

Consensus $4.00 vs current $2.27